The S&T Committee serves as a forum for Alliance members to exchange ideas, information, and data on different science and technology issues within the regenerative medicine field.
This committee is responsible for formal interaction with Congress, congressional staff, and federal agencies including testifying, attending meetings, and other activities as appropriate.
The Regulatory Committee is responsible for interaction with regulatory agencies at public hearings, meetings, roundtables, PDUFA negotiations, submission of comments to the regulatory docket, and other forums for public discussion
The Communication and Education Committee is responsible for overseeing the Alliance’s communications activities, including interaction with the media and public education.
This committee works closely with the investment community while also advocating for federal and state policies that promote capital formation in regenerative medicine.
Join over 600 expected international delegates for ISCT’s 19th Annual Meeting in Auckland, New Zealand including MD and/or PhD clinicians and scientists, industry personnel from cell therapy or enabling technology companies and regulatory professionals.
Presentations from FDA and Leading Experts
This year’s Advanced Therapies Summit will be focused on the innovation interests driving companies, academic institutes and other organizations involved in cell therapy, regenerative medicine, gene therapy and other potentially life-saving advanced therapeutics.
